Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma. - Wikidata - wikimedia - TriplyDB

Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma.

Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q33685325

about

Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge.Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.

P2860

Q48333559-B481614E-CCBB-4A5E-9BD1-196223E9D1F2 Q55284623-71FA11D1-9F46-4F60-910A-31A9FF8A6D0D

P2860

Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q33685325

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Clinicopathological implicatio ...... of pancreatic adenocarcinoma.

@ast

Clinicopathological implicatio ...... of pancreatic adenocarcinoma.

@en

type

label

Clinicopathological implicatio ...... of pancreatic adenocarcinoma.

@ast

Clinicopathological implicatio ...... of pancreatic adenocarcinoma.

@en

prefLabel

Clinicopathological implicatio ...... of pancreatic adenocarcinoma.

@ast

Clinicopathological implicatio ...... of pancreatic adenocarcinoma.

@en

P1433

Q33685325-44DBFD98-3E04-40CF-B1DE-6019A83EA3A5

P1476

Q33685325-604CF732-CF51-41B4-9D1F-76C3B51AA727

P2093

Q33685325-096874D4-402E-472E-B23C-D3D6E08EBED5

Q33685325-0C8B44DA-B55E-4D1D-8611-6540B32B7D3F

Q33685325-53CEEC91-C679-4C09-AA10-8D476561F3CB

Q33685325-68CFCCE6-5725-4478-88CC-72FE66BA0A34

Q33685325-A2572485-49EC-4398-A56F-B718C689AEE5

Q33685325-D09C014F-DB99-4A27-962D-49054B5EDE39

Q33685325-EAE87C76-2E18-49AA-8166-25944AD9035C

P2860

Q33685325-0771A77B-8E3D-4A1F-A9F5-13F8D0B5C9EF

Q33685325-0E629C73-F0FE-4C82-B00D-534046D283C7

Q33685325-15F79F8E-C0C7-42A3-AE01-0A6E5DEAC618

Q33685325-1B2FE18D-C352-4522-A174-4B8EBCC2CEE1

Q33685325-25131701-B504-4F4C-9530-827923C85780

Q33685325-2CE940E5-A5EB-4F5B-97B0-CBC73E2550B8

Q33685325-61EC185D-3BDB-497D-AC89-37283F832CB7

Q33685325-6B54B01D-EEBE-493F-94B4-51CA42FE186B

Q33685325-9CB46493-D8A7-492A-BA35-D5DAE2A4D4AF

Q33685325-A45010A6-E07D-4583-B376-B9AD80928046

P304

Q33685325-C4D8EACB-3DD1-477E-B6EF-D7B8E23FAF74

P31

Q33685325-2EA546EB-C0D6-4E4D-B962-F7FD3B213889

P356

Q33685325-5918C312-2520-42F9-A9F1-038EB2981DD9

P433

Q33685325-FD0D5770-1568-4596-BB7D-D9D5FC2F2194

P478

Q33685325-45B0117E-0AEA-4B1E-AD96-D156085622A3

P577

Q33685325-F1EC31B4-AA88-4049-8FA2-5CE945EFB19A

P698

Q33685325-79B14358-0B37-436A-8C7C-D29FC28D160A

P921

Q33685325-15106706-18FB-49BD-B661-49090A7363B8

Q33685325-7C9FCA29-BD57-41C9-AC3F-85055ED76427

P932

Q33685325-6E92220F-27EB-4EC5-8912-255164B02AB2

P356

P1433

Oncology Letters

P1476

Clinicopathological implicatio ...... of pancreatic adenocarcinoma.

@en

P2093

Aihua Jin

http://www.w3.org/2001/XMLSchema#string

Jie Sun

http://www.w3.org/2001/XMLSchema#string

Liyan Chen

http://www.w3.org/2001/XMLSchema#string

Meiying Ji

http://www.w3.org/2001/XMLSchema#string

Xuelian Cui

http://www.w3.org/2001/XMLSchema#string

Yang Yang

http://www.w3.org/2001/XMLSchema#string

Zhenhua Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms

NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells

Sulindac compounds facilitate the cytotoxicity of β-lapachone by up-regulation of NAD(P)H quinone oxidoreductase in human lung cancer cells

Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.

Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł.

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials.

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.

NQO1 C609T polymorphism correlated to colon cancer risk in farmers from western region of Inner Mongolia.

P304

2996-3002

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.5821

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28521407

http://www.w3.org/2001/XMLSchema#string

P921

P932

5431416

http://www.w3.org/2001/XMLSchema#string